
Nucala Coupons & Discount Card - Compare Prices Near You
My prescription
Edit
100MG, Nucala (30 Solution Reconstituteds)
Select pharmacy

Rite Aid
$105532.65
COUPON PRICE
Walgreens
$109984.19
COUPON PRICENucala savings card
Show this card to your pharmacist
Rite Aid
$105532.65
BIN
ID
PCN
GRP
019876
LH8DBBF5FD
CHIPPO
LHX
Powered by
Related interleukin antagonists prescriptions
More prescriptions for asthma
Related interleukin antagonists prescriptions
More prescriptions for asthma
Nucala dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
100MG | 30 Solution Reconstituteds | $106814.97 | $3560.5 |
Nucala Warnings
This information outlines critical safety considerations for the use of Nucala (mepolizumab). It is important to read and understand these warnings, and consult your healthcare provider if you have any questions or concerns.
Allergic Reactions: Nucala (mepolizumab) has the potential to cause severe allergic reactions, such as hives, wheezing, breathing difficulties, or swelling of the face, mouth, tongue, or throat (anaphylaxis). These reactions may occur within hours or even days after administration. Therefore, initial treatments should be conducted under medical supervision, with close monitoring following each dose to ensure no serious reactions occur. If you experience any symptoms of an allergic reaction outside a healthcare facility, seek emergency medical help immediately by calling 911.
Not for Acute Asthma Attacks: Nucala (mepolizumab) is designed to be an adjunctive maintenance therapy for asthma, meant to be used alongside other asthma medications for long-term management. It is not suitable for treating acute asthma attacks; for immediate relief during an asthma attack, use a rescue inhaler such as albuterol.
Corticosteroid Use: If you are on oral or inhaled corticosteroids, do not abruptly discontinue them without consulting your healthcare provider, even if you notice improvements with Nucala (mepolizumab). Stopping corticosteroids suddenly can lead to withdrawal symptoms such as dizziness, extreme fatigue, body aches, and vomiting. Your healthcare provider will guide you on how to safely reduce or discontinue corticosteroid use if necessary.
Infection Risk: There is a rare risk of developing herpes zoster (shingles) while on Nucala (mepolizumab). Discuss with your healthcare provider whether you should receive the herpes zoster vaccine (Shingrix) before starting this medication.
Nucala Side Effects
When using this medication, there are a few common side effects that may occur. These include headaches and reactions at the injection site, such as pain, redness, swelling, itching, or burning. These are generally mild and affect a small percentage of users. Fatigue and back pain are also reported but are usually manageable. If these effects persist or worsen, consulting a healthcare provider is advisable to ensure your comfort and safety.
In addition to the common side effects, some individuals may experience throat or joint pain. While these are less common, they should be monitored. If the symptoms become bothersome or more severe, it's important to contact a healthcare provider for guidance.
Although serious side effects are rare, it is crucial to be aware of them. A severe allergic reaction, identified by symptoms such as a rash, swelling of the face, tongue, or throat, severe dizziness, or difficulty breathing, requires immediate medical attention. Muscle aches, pain, or spasms should also be promptly reported to a healthcare professional. Remember, while these severe reactions are unlikely, being informed helps you respond effectively should they occur.
What exactly does NUCALA do?
NUCALA (mepolizumab) is a monoclonal antibody that targets and inhibits interleukin-5 (IL-5), a protein involved in the growth and survival of eosinophils, which are a type of white blood cell. By reducing the levels of eosinophils, NUCALA helps manage conditions characterized by high eosinophil counts, such as severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (HES). It is used as an add-on maintenance treatment to help control symptoms and reduce the frequency of exacerbations in these conditions.
How much does a NUCALA shot cost?
The cost of a NUCALA (mepolizumab) injection can vary depending on factors such as location, insurance coverage, and the pharmacy or healthcare provider. On average, the price without insurance can range from $3,000 to $5,000 per injection. Patients are advised to check with their insurance provider for coverage details and potential out-of-pocket costs. Additionally, there may be patient assistance programs available to help reduce the cost.
Does NUCALA cause weight gain?
Weight gain is not commonly reported as a side effect of NUCALA (mepolizumab). However, individual reactions to medications can vary. If there are concerns about weight changes while taking NUCALA, it is advisable to consult with a healthcare provider for personalized advice and evaluation.
What is the difference between NUCALA and Dupixent?
NUCALA (mepolizumab) and Dupixent (dupilumab) are both biologic medications used to treat different conditions, although there is some overlap. NUCALA is primarily used for severe eosinophilic asthma and other eosinophilic conditions, working by targeting interleukin-5 (IL-5) to reduce eosinophil levels. Dupixent, on the other hand, is used for moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. It targets interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways to reduce inflammation. The choice between them depends on the specific condition being treated and the patient's medical history.
How do you know if Nucala is working?
The effectiveness of Nucala can be assessed by monitoring the patient's symptoms and overall health. If Nucala is working, the patient may experience a reduction in the frequency and severity of asthma attacks, improved lung function, and a decrease in the need for oral corticosteroids. Additionally, the patient might notice an improvement in their ability to perform daily activities without experiencing asthma-related symptoms. Regular follow-up appointments with a healthcare provider are essential to evaluate the treatment's effectiveness and make any necessary adjustments.